 | • レポートコード：MR2211MG10938 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、創傷・皮膚感染症治療のグローバル市場規模と予測を記載しています。・創傷・皮膚感染症治療のグローバル市場：売上、2017年-2022年、2023年-2028年 ・創傷・皮膚感染症治療のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 創傷・皮膚感染症治療のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「従来型治療」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 創傷・皮膚感染症治療のグローバル主要企業は、3M、 Coloplast、 B. Braun Melsungen、 Smith & Nephew、 Genzyme、 ConvaTec Healthcare、 Human BioSciences、 MediPurpose、 Medtronic、 J&J Medical、 Acelity、 Carinal Health、 Medline、 Integra LifeSciences、 MiMedx Group、 Mölnlyckeなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、創傷・皮膚感染症治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の創傷・皮膚感染症治療市場：タイプ別、2017年-2022年、2023年-2028年 世界の創傷・皮膚感染症治療市場：タイプ別市場シェア、2021年 ・従来型治療、一般型治療、生理活性型治療、先進型治療 世界の創傷・皮膚感染症治療市場：用途別、2017年-2022年、2023年-2028年 世界の創傷・皮膚感染症治療市場：用途別市場シェア、2021年 ・バイオテクノロジー企業、製薬企業、病院検査室・診断検査室、学術・研究機関、その他 世界の創傷・皮膚感染症治療市場：地域・国別、2017年-2022年、2023年-2028年 世界の創傷・皮膚感染症治療市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における創傷・皮膚感染症治療のグローバル売上、2017年-2022年 ・主要企業における創傷・皮膚感染症治療のグローバル売上シェア、2021年 ・主要企業における創傷・皮膚感染症治療のグローバル販売量、2017年-2022年 ・主要企業における創傷・皮膚感染症治療のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 3M、 Coloplast、 B. Braun Melsungen、 Smith & Nephew、 Genzyme、 ConvaTec Healthcare、 Human BioSciences、 MediPurpose、 Medtronic、 J&J Medical、 Acelity、 Carinal Health、 Medline、 Integra LifeSciences、 MiMedx Group、 Mölnlycke ************************************************************* ・調査・分析レポートの概要 創傷・皮膚感染症治療市場の定義 市場セグメント 世界の創傷・皮膚感染症治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の創傷・皮膚感染症治療市場規模 世界の創傷・皮膚感染症治療市場規模：2021年 VS 2028年 世界の創傷・皮膚感染症治療市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの創傷・皮膚感染症治療の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の創傷・皮膚感染症治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：従来型治療、一般型治療、生理活性型治療、先進型治療 創傷・皮膚感染症治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：バイオテクノロジー企業、製薬企業、病院検査室・診断検査室、学術・研究機関、その他 創傷・皮膚感染症治療の用途別グローバル売上・予測 ・地域別市場分析 地域別創傷・皮膚感染症治療市場規模 2021年と2028年 地域別創傷・皮膚感染症治療売上・予測 北米市場 - アメリカの創傷・皮膚感染症治療市場規模2017年-2028年 - カナダの創傷・皮膚感染症治療市場規模2017年-2028年 - メキシコの創傷・皮膚感染症治療市場規模2017年-2028年 ヨーロッパ市場 - ドイツの創傷・皮膚感染症治療市場規模2017年-2028年 - フランスの創傷・皮膚感染症治療市場規模2017年-2028年 - イギリスの創傷・皮膚感染症治療市場規模2017年-2028年 - イタリアの創傷・皮膚感染症治療市場規模2017年-2028年 - ロシアの創傷・皮膚感染症治療市場規模2017年-2028年 アジア市場 - 中国の創傷・皮膚感染症治療市場規模2017年-2028年 - 日本の創傷・皮膚感染症治療市場規模2017年-2028年 - 韓国の創傷・皮膚感染症治療市場規模2017年-2028年 - 東南アジアの創傷・皮膚感染症治療市場規模2017年-2028年 - インドの創傷・皮膚感染症治療市場規模2017年-2028年 南米市場 - ブラジルの創傷・皮膚感染症治療市場規模2017年-2028年 - アルゼンチンの創傷・皮膚感染症治療市場規模2017年-2028年 中東・アフリカ市場 - トルコの創傷・皮膚感染症治療市場規模2017年-2028年 - イスラエルの創傷・皮膚感染症治療市場規模2017年-2028年 - サウジアラビアの創傷・皮膚感染症治療市場規模2017年-2028年 - UAEの創傷・皮膚感染症治療市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） 3M、 Coloplast、 B. Braun Melsungen、 Smith & Nephew、 Genzyme、 ConvaTec Healthcare、 Human BioSciences、 MediPurpose、 Medtronic、 J&J Medical、 Acelity、 Carinal Health、 Medline、 Integra LifeSciences、 MiMedx Group、 Mölnlycke ... |
Wound and skin infection treatment is of extreme importance as they are potent to complicate morbidity and cause anxiety which subsequently leads to patient discomfort and ultimately death. In order to treat a wound infection, a physician in common carries out advance wound treatment procedure using hydrogels, alginates, foam dressings, collagen and other wound care products. As advanced wound treatment provides effective and efficient solution by allowing fast healing of wounds, thus it is most commonly preferred over traditional treatment methods. Surgical wounds are further referred to as surgical site infection (SSI) by the US Centre for Disease Control and Prevention (CDC). About 77% of the deaths of surgical patients were related to surgical wound infection.
This report contains market size and forecasts of Wound and Skin Infection Treatment in Global, including the following market information:
Global Wound and Skin Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Wound and Skin Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Traditional Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wound and Skin Infection Treatment include 3M, Coloplast, B. Braun Melsungen, Smith & Nephew, Genzyme, ConvaTec Healthcare, Human BioSciences, MediPurpose and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wound and Skin Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wound and Skin Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Wound and Skin Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Traditional Treatment
Basic Treatment
Bio-Active Treatment
Advanced Treatment
Global Wound and Skin Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Wound and Skin Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
Global Wound and Skin Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Wound and Skin Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wound and Skin Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Wound and Skin Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Coloplast
B. Braun Melsungen
Smith & Nephew
Genzyme
ConvaTec Healthcare
Human BioSciences
MediPurpose
Medtronic
J&J Medical
Acelity
Carinal Health
Medline
Integra LifeSciences
MiMedx Group
Mölnlycke
1 Introduction to Research & Analysis Reports
1.1 Wound and Skin Infection Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Wound and Skin Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Wound and Skin Infection Treatment Overall Market Size
2.1 Global Wound and Skin Infection Treatment Market Size: 2021 VS 2028
2.2 Global Wound and Skin Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Wound and Skin Infection Treatment Players in Global Market
3.2 Top Global Wound and Skin Infection Treatment Companies Ranked by Revenue
3.3 Global Wound and Skin Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Wound and Skin Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Wound and Skin Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Wound and Skin Infection Treatment Players in Global Market
3.6.1 List of Global Tier 1 Wound and Skin Infection Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Wound and Skin Infection Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Wound and Skin Infection Treatment Market Size Markets, 2021 & 2028
4.1.2 Traditional Treatment
4.1.3 Basic Treatment
4.1.4 Bio-Active Treatment
4.1.5 Advanced Treatment
4.2 By Type – Global Wound and Skin Infection Treatment Revenue & Forecasts
4.2.1 By Type – Global Wound and Skin Infection Treatment Revenue, 2017-2022
4.2.2 By Type – Global Wound and Skin Infection Treatment Revenue, 2023-2028
4.2.3 By Type – Global Wound and Skin Infection Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Wound and Skin Infection Treatment Market Size, 2021 & 2028
5.1.2 Biotechnology Companies
5.1.3 Pharmaceutical Companies
5.1.4 Hospital Laboratory and Diagnostic Laboratory
5.1.5 Academic and Research Institutes
5.1.6 Others
5.2 By Application – Global Wound and Skin Infection Treatment Revenue & Forecasts
5.2.1 By Application – Global Wound and Skin Infection Treatment Revenue, 2017-2022
5.2.2 By Application – Global Wound and Skin Infection Treatment Revenue, 2023-2028
5.2.3 By Application – Global Wound and Skin Infection Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Wound and Skin Infection Treatment Market Size, 2021 & 2028
6.2 By Region – Global Wound and Skin Infection Treatment Revenue & Forecasts
6.2.1 By Region – Global Wound and Skin Infection Treatment Revenue, 2017-2022
6.2.2 By Region – Global Wound and Skin Infection Treatment Revenue, 2023-2028
6.2.3 By Region – Global Wound and Skin Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Wound and Skin Infection Treatment Revenue, 2017-2028
6.3.2 US Wound and Skin Infection Treatment Market Size, 2017-2028
6.3.3 Canada Wound and Skin Infection Treatment Market Size, 2017-2028
6.3.4 Mexico Wound and Skin Infection Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Wound and Skin Infection Treatment Revenue, 2017-2028
6.4.2 Germany Wound and Skin Infection Treatment Market Size, 2017-2028
6.4.3 France Wound and Skin Infection Treatment Market Size, 2017-2028
6.4.4 U.K. Wound and Skin Infection Treatment Market Size, 2017-2028
6.4.5 Italy Wound and Skin Infection Treatment Market Size, 2017-2028
6.4.6 Russia Wound and Skin Infection Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Wound and Skin Infection Treatment Market Size, 2017-2028
6.4.8 Benelux Wound and Skin Infection Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Wound and Skin Infection Treatment Revenue, 2017-2028
6.5.2 China Wound and Skin Infection Treatment Market Size, 2017-2028
6.5.3 Japan Wound and Skin Infection Treatment Market Size, 2017-2028
6.5.4 South Korea Wound and Skin Infection Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Wound and Skin Infection Treatment Market Size, 2017-2028
6.5.6 India Wound and Skin Infection Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Wound and Skin Infection Treatment Revenue, 2017-2028
6.6.2 Brazil Wound and Skin Infection Treatment Market Size, 2017-2028
6.6.3 Argentina Wound and Skin Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Wound and Skin Infection Treatment Revenue, 2017-2028
6.7.2 Turkey Wound and Skin Infection Treatment Market Size, 2017-2028
6.7.3 Israel Wound and Skin Infection Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Wound and Skin Infection Treatment Market Size, 2017-2028
6.7.5 UAE Wound and Skin Infection Treatment Market Size, 2017-2028
7 Players Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Wound and Skin Infection Treatment Major Product Offerings
7.1.4 3M Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.1.5 3M Key News
7.2 Coloplast
7.2.1 Coloplast Corporate Summary
7.2.2 Coloplast Business Overview
7.2.3 Coloplast Wound and Skin Infection Treatment Major Product Offerings
7.2.4 Coloplast Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.2.5 Coloplast Key News
7.3 B. Braun Melsungen
7.3.1 B. Braun Melsungen Corporate Summary
7.3.2 B. Braun Melsungen Business Overview
7.3.3 B. Braun Melsungen Wound and Skin Infection Treatment Major Product Offerings
7.3.4 B. Braun Melsungen Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.3.5 B. Braun Melsungen Key News
7.4 Smith & Nephew
7.4.1 Smith & Nephew Corporate Summary
7.4.2 Smith & Nephew Business Overview
7.4.3 Smith & Nephew Wound and Skin Infection Treatment Major Product Offerings
7.4.4 Smith & Nephew Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.4.5 Smith & Nephew Key News
7.5 Genzyme
7.5.1 Genzyme Corporate Summary
7.5.2 Genzyme Business Overview
7.5.3 Genzyme Wound and Skin Infection Treatment Major Product Offerings
7.5.4 Genzyme Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.5.5 Genzyme Key News
7.6 ConvaTec Healthcare
7.6.1 ConvaTec Healthcare Corporate Summary
7.6.2 ConvaTec Healthcare Business Overview
7.6.3 ConvaTec Healthcare Wound and Skin Infection Treatment Major Product Offerings
7.6.4 ConvaTec Healthcare Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.6.5 ConvaTec Healthcare Key News
7.7 Human BioSciences
7.7.1 Human BioSciences Corporate Summary
7.7.2 Human BioSciences Business Overview
7.7.3 Human BioSciences Wound and Skin Infection Treatment Major Product Offerings
7.7.4 Human BioSciences Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.7.5 Human BioSciences Key News
7.8 MediPurpose
7.8.1 MediPurpose Corporate Summary
7.8.2 MediPurpose Business Overview
7.8.3 MediPurpose Wound and Skin Infection Treatment Major Product Offerings
7.8.4 MediPurpose Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.8.5 MediPurpose Key News
7.9 Medtronic
7.9.1 Medtronic Corporate Summary
7.9.2 Medtronic Business Overview
7.9.3 Medtronic Wound and Skin Infection Treatment Major Product Offerings
7.9.4 Medtronic Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.9.5 Medtronic Key News
7.10 J&J Medical
7.10.1 J&J Medical Corporate Summary
7.10.2 J&J Medical Business Overview
7.10.3 J&J Medical Wound and Skin Infection Treatment Major Product Offerings
7.10.4 J&J Medical Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.10.5 J&J Medical Key News
7.11 Acelity
7.11.1 Acelity Corporate Summary
7.11.2 Acelity Business Overview
7.11.3 Acelity Wound and Skin Infection Treatment Major Product Offerings
7.11.4 Acelity Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.11.5 Acelity Key News
7.12 Carinal Health
7.12.1 Carinal Health Corporate Summary
7.12.2 Carinal Health Business Overview
7.12.3 Carinal Health Wound and Skin Infection Treatment Major Product Offerings
7.12.4 Carinal Health Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.12.5 Carinal Health Key News
7.13 Medline
7.13.1 Medline Corporate Summary
7.13.2 Medline Business Overview
7.13.3 Medline Wound and Skin Infection Treatment Major Product Offerings
7.13.4 Medline Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.13.5 Medline Key News
7.14 Integra LifeSciences
7.14.1 Integra LifeSciences Corporate Summary
7.14.2 Integra LifeSciences Business Overview
7.14.3 Integra LifeSciences Wound and Skin Infection Treatment Major Product Offerings
7.14.4 Integra LifeSciences Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.14.5 Integra LifeSciences Key News
7.15 MiMedx Group
7.15.1 MiMedx Group Corporate Summary
7.15.2 MiMedx Group Business Overview
7.15.3 MiMedx Group Wound and Skin Infection Treatment Major Product Offerings
7.15.4 MiMedx Group Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.15.5 MiMedx Group Key News
7.16 Mölnlycke
7.16.1 Mölnlycke Corporate Summary
7.16.2 Mölnlycke Business Overview
7.16.3 Mölnlycke Wound and Skin Infection Treatment Major Product Offerings
7.16.4 Mölnlycke Wound and Skin Infection Treatment Revenue in Global Market (2017-2022)
7.16.5 Mölnlycke Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer